Tagged with R

Korea Nic Horridge was recently appointed president of Roche Korea, having spent an extended period in emerging Asian markets. He shares his vision for the Korean affiliate, focused on bringing Roche’s extensive global pipeline of innovative medicines to Korean patients, making personalized healthcare a reality in clinics and championing Korea as…

France François Vorms, managing director of Canon Medical Systems France, shares the story of how the company navigated its transition from Toshiba to become a well-known player in the medical imaging market today. Additionally, Vorms comments on the highly advanced AI initiatives the affiliate is taking, namely its Aquilion ONE™ /…

Mexico Cristobal Thompson of the AMIIF examines the steps forward that Mexican pharma has made in countering corruption, the areas in which urgent improvement is still needed, and outlines the three key reasons why fighting corrupt practices is so important.   The pharmaceutical industry must act according to value-based codes, building…

Portugal Joana Silveira Botelho of Cuatrecasas argues for the need for an EU-wide regulatory update on the advertising of pharmaceutical products online, given current rules do not take into account the spread and influence of social media today.   Today’s internet is so much more than a company’s website It is…

China Dr Jun Bao, appointed president and CEO of Impact Therapeutics in October 2018, shares his aspirations for Impact to be a leader in synthetic lethality in oncology; the importance of ‘operating locally but selling globally’; his learnings from his distinguished career across biotech and pharma companies in the US and…

Korea iCure is a Korean company applying its advanced transdermal delivery technology to pharmaceuticals and dermo-cosmetics. The company has developed the first-ever transdermal patch for donepezil to reach Phase III clinical trials. Its CEO, Young Kweon Choi, shares his plans for this novel pharmaceutical product, as well as the company’s line…

Egypt Dr Mohsen Shalaby, President of Nerhadou, explains how he has built Egypt’s leading mineral supplement and nutraceuticals company from scratch within 25 years. He highlights Nerhadou’s innovative solutions and the company’s aspirations to export to overseas markets upon receiving FDA approval.   Nerhadou has been the first mover in the…

China Click here to register and download PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: China.   From the world’s ninth largest pharma market in 2007 to its second-biggest merely 12 years later, China and its growth story are impossible to ignore. China now accounts for a significant share of revenues…

France Elie Lobel, CEO of Orange Healthcare, explains how digitalization is bringing together stakeholders from across the healthcare continuum, allowing increased information exchange and connectivity. Lobel also gives insight into the latest projects the company is working on to digitally transform healthcare.   Access to healthcare is a critical issue around…

France Eric Le Roy, director general of SNITEM (Syndicat National de l’Industrie des Technologies Médicales, The French National Association of the Medical Technologies Industry) discusses the profile of French medtech today, the key trends and challenges its stakeholders are facing, and the top priorities for change he and his members expect…

Spain Javier Hidalgo, CEO and president of Tedec-Meiji Farma, highlights the main challenges he faces and how he positions the company as the preferred partner of choice. Furthermore, he offers his insights into the strategic importance of Spain for the group and how he blends the two cultures of the company,…

France Vincent Pont, president of Laboratoire Arrow, explains the company’s history, its collaboration with Aurobindo, the Indian generic pharmaceuticals group, the company’s unique positioning as a leader in the generic hospital sector, and its future growth strategies.   Generics companies need a wide portfolio to meet all of the generics needs…